On 15 June 2026, the Spanish government in Madrid unveiled the programme “Somos. Contamos” to end discrimination against women in health research. According to La Moncloa the head of government announced Pedro Sánchez at the Fundación Ortega-Marañón to raise targeted funding for research into women’s health to €18 million a year and launch new funding streams. The aim is to correct structural biases that contribute to misdiagnosis and delayed treatment in research and healthcare.
Context and examples: Experts have pointed for years to gaps in accounting for sex-specific differences. Examples include the long time taken to diagnose Endometriosis, misinterpretation of heart attacks with atypical symptoms, and the tendency to psychologise chronic pain in women. Critics say Spain’s research landscape often follows male-standard models, from hypothesis formation to the endpoints used in clinical trials.
Institutional background: The Ministerio de Sanidad and bodies under its authority, such as the Instituto de Salud Carlos III and the Agencia Española de Medicamentos y Productos Sanitarios have been working for years on guidelines requiring analysis by sex. Implementation nonetheless remains uneven, including in data collection, analysis by sex and age, and the transfer of research findings into clinical practice.
Assessments and possible effects: Experts welcome the additional funding as a necessary impetus. In their view, however, the programme will only be effective if funding calls include binding criteria for study designs, ethics committees and review bodies monitor compliance, and hospitals incorporate the findings into treatment guidelines. They are calling for monitoring indicators with deadlines, open reports on funding decisions, and training for clinical staff.
Separating the different elements: – Facts: The government’s announcement on 15 June 2026, its presentation by Pedro Sánchez at the Fundación Ortega-Marañón in Madrid, and the planned increase to €18 million a year, all according to La Moncloa. – Attributed statements: References to an almost ten-year delay before endometriosis is diagnosed and criticism of the androcentric focus of research come from government speeches and specialist articles. – Projections: Expected improvements in diagnosis and treatment depend on specific requirements, oversight and evaluation mechanisms; their impact remains uncertain.
“Somos. Contamos” will therefore be a test for Spain of whether political announcements can be translated into lasting gender-equitable health research and healthcare.
Editor: Clara Simonichek (Article created with AI assistance).